MOESM1 of The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Additional file 1: Table S1. Statistical correlation of individual gene expression with response and survival in the whole cohort and in the NSCLC cohort.

附加文件1：表S1。全队列与非小细胞肺癌（Non-Small Cell Lung Cancer, NSCLC）队列中单个基因表达量与治疗应答及生存情况的统计学相关性分析。